Yonsei University
π°π·South Korea
- Country
- π°π·South Korea
- Ownership
- Private
- Established
- 1885-01-01
- Employees
- 5K
- Market Cap
- -
- Website
- http://www.yonsei.ac.kr
Comparison of Functional Recovery After Total Knee Arthroplasty Between Low Phase Angle and High Phase Angle Group
Recruiting
- Conditions
- Knee Osteoarthritis
- First Posted Date
- 2024-11-22
- Last Posted Date
- 2025-02-07
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 200
- Registration Number
- NCT06701474
- Locations
- π°π·
Yongin Severance Hospital, Yongin-si, Gyeonggi-do, Korea, Republic of
A Comparison of High-flow Nasal Oxygen and Conventional Nasal Cannula in Monitored Anesthesia Care for Endoscopic Submucosal Dissection
Not Applicable
Not yet recruiting
- Conditions
- Patients Undergoing Endoscopic Submucosal Dissection
- First Posted Date
- 2024-11-14
- Last Posted Date
- 2024-11-14
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 200
- Registration Number
- NCT06688019
Efficacy and Safety of Symptom Improvement by Digital Therapeutics to Manage Hypotension Symptoms
Not Applicable
Not yet recruiting
- Conditions
- Hypotension
- First Posted Date
- 2024-11-13
- Last Posted Date
- 2024-11-13
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 44
- Registration Number
- NCT06685900
- Locations
- π°π·
Yonsei university college of medicine, Seoul, Korea, Republic of
Preoperative Partial Breast Irradiation in Early-Stage Breast Cancer
Phase 2
Recruiting
- Conditions
- Breast CancerDuctal Carcinoma in SituInvasive Breast Cancer
- First Posted Date
- 2024-11-07
- Last Posted Date
- 2024-11-07
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 47
- Registration Number
- NCT06677944
- Locations
- π°π·
Department of Radiation Oncology, Yonsei University College of Medicine, Seoul, Korea, Republic of
Outcome in Patients Treated With Endovascular Thrombectomy - optIMAL Blood Pressure Control 2 (OPTIMAL-BP 2)
Phase 3
Recruiting
- Conditions
- Acute Ischemic Stroke
- Interventions
- Drug: BP raising drug (phenylephrine) or BP lowering drugs (nicardipine, labetalol, urapidil)Drug: BP lowering drugs (nicardipine, labetalol, urapidil)
- First Posted Date
- 2024-11-07
- Last Posted Date
- 2025-01-14
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 176
- Registration Number
- NCT06677970
- Locations
- π°π·
Department of Neurology, Yonsei University College of Medicine, Seoul, Korea, Republic of
Association Between Post-operative Anemia and Mortality After Valvular Heart Surgery
Active, not recruiting
- Conditions
- Patients Undergoing Valvular Heart Surgery
- First Posted Date
- 2024-10-18
- Last Posted Date
- 2024-10-18
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 3000
- Registration Number
- NCT06647758
- Locations
- π°π·
Department of Anesthesiology and Pain Medicine and Anesthesia, Seoul, Korea, Republic of
Relationship Between Postoperative Tempeartive and Acute Kidney Injury
Active, not recruiting
- Conditions
- Patients Undergoing Valvular Heart Surgery
- First Posted Date
- 2024-10-18
- Last Posted Date
- 2024-10-18
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 3274
- Registration Number
- NCT06647771
- Locations
- π°π·
Department of Anesthesiology and Pain Medicine, Yonsei University College of Medicine, Seoul, Korea, Republic of
A Prospective Trial of Enavogliflozin to Evaluate Cardio-renal Outcome in Type 2 Diabetes Mellitus Patients
Phase 4
Recruiting
- Conditions
- Diabetes Mellitus, Type 2Cardiovascular DiseasesKidney Diseases
- Interventions
- First Posted Date
- 2024-10-15
- Last Posted Date
- 2024-10-15
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 2862
- Registration Number
- NCT06642623
- Locations
- π°π·
Department of Internal Medicine, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Republic of Korea, Seoul, Korea, Republic of
Efficacy of RUS GA Surgical Navigation for Robot-assisted Distal Gastrectomy in Gastric Cancer Patients
Not Applicable
Not yet recruiting
- Conditions
- Gastric Cancer
- First Posted Date
- 2024-10-14
- Last Posted Date
- 2024-10-14
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 330
- Registration Number
- NCT06639490
Clinical Validation of PROPECG-TMT
Completed
- Conditions
- Coronary Artery Disease
- Interventions
- Other: Screening for coronary artery revascularization based on TMT-ECG
- First Posted Date
- 2024-10-03
- Last Posted Date
- 2024-10-03
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 100
- Registration Number
- NCT06624852
- Locations
- π°π·
Department of Biomedicine Systems Informatics, Yonsei University College of Medicine, Seoul, Korea, Republic of
Β© Copyright 2025. All Rights Reserved by MedPath